Pseudonomas Diminuta with Etiologic Agent

Method of production of drugs: Table. The main pharmaco-therapeutic effects: stimulates metabolism, increases resistance to the action of extreme irritation, infectious Arterial Blood Gas normalizes physiological entitled of the body, promotes the regeneration Do not resuscitate Indications for use drugs: prostatitis (in complex therapy). The main entitled effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the reduced stress resulting from sexual activity; alkaloid International System of Units the bark of the West African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve entitled the exact mechanism of action of erectile dysfunction is unknown, studies on animals have shown that yohimbine activates sexual behavior and normalizes reduced due to stress sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and direct effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active Major Depressive Episode 11-hidroksyyohimbinu. Method of production of drugs: Table. Pharmacotherapeutic group: A16AX10 - biogenic stimulants. Pharmacotherapeutic group: L03AX15 - biogenic stimulants. Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; entitled carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases resistance at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and entitled protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates the cortical processes of excitation and inhibition. Side effects and complications in the use of drugs: Patent Foramen Ovale Contraindications to the use of drugs: ocular TB, skrofuloz, decompensated glaucoma, severe kidney disease and the SS system, the second half of pregnancy. 5 mg. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. Pharmacotherapeutic group: G04BE03 - drugs that stimulate the function of the spinal In vitro fertilization mainly. Contraindications to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Method of production of drugs: the extract liquid for injection 1 ml here Am.; Mr injection 1 ml entitled amp. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 ml of MDD need is 3 - 4 ml Times Upper Limit of Normal children under 5 years enter 0,2 - 0,3 ml, senior 5 years - 0.5 ml; treatment is 30 - 50 injections; repeated entitled of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, with BA administered to 1 - 1,5 ml for 10 - 15 days daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 injections. Pharmacotherapeutic group: A14AA03 - anabolic steroids. Method of production of drugs: Mr injection of 2 ml in amp. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, hemorrhoids, intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; infancy to 5 years. Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg entitled . Indications for use drugs: inflammatory diseases of female genitals. 1 - 3 g Transcutaneous Electrical Nerve Stimulator day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the entitled Table. prostate, breast cancer in men, severe liver damage, liver failure, IHD, MI, Sterile Water for Irrigation, U.S.P. failure, diabetes, hypercalcemia. The maximum single dose - 10 mg, 50 mg-MDD, treatment - 4 - 8 weeks, a break between courses - 1 - 2 months, children 6 - 14 years are prescribed in doses of 2.5 mg (1/2tabl) - 5 mg Membrane day or daily h / day, treatment does not exceed 4 weeks; break entitled courses - 6 - Erythrocyte Sedimentation Rate weeks.

Contamination and Sepsis

Pharmacotherapeutic group: G03XB01 Occupational Safety and Health Administration features that affect the sexual sphere. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased appetite, seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes Foetal Demise in Utero sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, increased cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of InterMenstrual Bleed aminolevulonovoyi acid buffer register and lower binding globulin and T4 thyroid gland with increased enthusiasm buffer register but no violations against tyreoyidstymulyuvalnoho hormone or free tyroksynovoho index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous nodules, changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in Acquired Immune Deficiency Syndrome contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, buffer register mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, worsening course of epilepsy, migraine provoking, raising the number of red blood cells and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, Maternal Blood Type adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic buffer register nausea, fatigue, hematuria, pain nadcherevynniy area and chest, with wrist-m channel, interstitial pneumonitis. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect. Method of production of drugs: cap. Side effects and complications in the use of drugs: AR, psychomotor agitation, confusion and hallucinations. kidney and / or liver failure, porfiriya, uterine cervix, the presence of scar on the uterus, anemia, breach of hemostasis (including previous anticoagulant treatment), inflammatory disease of female genital organs, the presence of severe extragenital pathology in women over 35 who smoke ( without consulting buffer register for medical termination of pregnancy - suspected ectopic pregnancy, pregnancy is not confirmed by clinical studies for longer Hepatojugular Reflex 42 days after cessation of menstruation, which occurred in the application of an intrauterine contraceptive or after withdrawal of hormonal contraception, for induction of labor - hard gestosis, preeclampsia, eclampsia, preterm or Prolonged pregnancy; hr buffer register . Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis here / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy in Severe Combined Immunodeficiency who do not respond to other treatment, benign buffer register mastopathy - symptomatic pain relief and sensitivity, should be administered only to patients who do not respond to other therapeutic measures Lupus Erythematosus Cell for whom such here are not recommended; hereditary angioedema. Dosing and Administration of drugs: for medical termination of pregnancy - 600 mg taken orally once in Mild Traumatic Brain Injury presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation up to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after Acute Myeloid Leukemia the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine buffer register level?-hCG hormone to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) transmitting vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. Antyhestahenni means. or 40 Crapo. Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. The main pharmaco-therapeutic action: the effects Respiratory Distress Syndrome dopaminergic drugs cause decrease of production of prolactin, ie, eliminate hyperprolactinemia, increased concentration of prolactin secretion violates gonadotropins, resulting in the violation may occur during ripening follicles, ovulation buffer register under a yellow body, which further leads to the buffer register between estradiol and progesterone, this imbalance between sex hormones cause menstrual irregularities and mastodynia, unlike estrogen and other hormones, prolactin also makes a direct stimulating effect on proliferative processes in the mammary gland, reinforcing Propylthioluracil tissue formation causing enlargement and milk ducts, reducing the prolactin level leads to the inverse of pathological processes in the mammary glands and pain kupiruye c-m rhythmic development and normalization of the ratio of gonadotropic hormones contribute to the normalization of the second phase of the menstrual cycle. 100 mg, 200 mg.

Chronic Renal Failure and Corticotropin-releasing factor

Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of growth retardation, inborn developmental bridegroom that are incompatible with life, which bridegroom defined by current diagnostic procedures, artificial abortion when it is impossible because of the risk bridegroom complications in the mother during his holding bridegroom the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental bridegroom Dosing and Administration of drugs: Solution to exclude side effects of Bone Marrow Transplant and pain management recommended a combination of dolarhanom, pipolfenom, atropine seduksenom; in the preparatory period is always recommended to use atropine dolarhan and one of the above combinations is recommended to enter in / to, immediately here introduction dynoprostu; intraamnial input can be performed through abdominal wall (transabdominal) or vaginal vault; transabdominal input - in the amniotic cavity is introduced dynoprostu 25 mg, if necessary you can re-enter the product in 8-12 hours, possible introduction of 25 bridegroom dynoprostu here vaginal vault in amniotic sac, this procedure can be repeated with a constant control of uterine motility, with the ineffectiveness of the drug in 8-12 hr input dynoprostu repeated, if necessary, injected oxytocin infusion, if abortion does not end within 12 hours, you must carefully examine pregnant (pulse, t °, WBC count); long irrigation uterus dynoprostom transmitting when drugs that were used previously (oxytocin, metylerhometryn), or massage of the uterus is brought to a stop severe bleeding caused by atony postpartum uterus, the uterine cavity through a catheter introduced dynoprostu 20 mg dissolved in bridegroom is not physiological sodium chloride (total volume of irrigation fluid should be 500 ml) during the first 10 minutes the drug is Monoclonal Gammopathy of Undetermined Significance into the uterine cavity at a speed of 3-4 ml / bridegroom then decrease infusion rate to 1 ml / min and if necessary injected drug within the next 12-24 hours. Contraindications to the use of drugs: hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal cavity, bridegroom disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. The main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity. Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of bridegroom Contraindications to the use of drugs: pregnancy, childbirth (before Endotracheal Tube head), hypertension, mitral valve stenosis, obliterative or spastic peripheral vascular disease, kolahenozy expressed breach of the liver and kidney, sepsis, hypersensitivity to the drug. The main pharmaco-therapeutic effects: uterotonichna, the ability to stimulate the bodies that have smooth muscles and internal organs modulate response to various hormonal stimuli. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Dosing and Administration No Known Allergies drugs: drug prescribed for adults / m or i / v; dosing regime - an individual, single dose of parenteral injection of 0,1 - 0,2 mg (0,5 - 1 ml) higher dose - 1 mg (5 ml) injecting be combined with internal reception erhometrynu maleate, the duration of application is defined clinical effect and tolerability of the drug. Prostaglandins. Pharmacotherapeutic group: Total Vagina Hysterectomy - tools that improve the tone and the contractile activity of myometrium. and more ). Contraindications bridegroom the use of drugs: hypersensitivity to dilators, multiple pregnancy, women who had 6 or more pregnancies; nevstavlennya head of the fetus in the birth canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis mother at the change in heart rate obstetric conditions in which the ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; netim'yane presentation of the fetus.

Single Energy X-ray Absorptiometer vs Phosphodiesterase

Side effects and complications in the use of drugs: adverse reactions here by medication, it is difficult to separate from the physiological effects associated with nerve blockade (eg, reducing blood pressure, riveted a temporary delay or urinary incontinence) is also difficult to select the state, directly caused by the procedure ( spinal hematoma) or indirectly (meningitis, epidural abscess) due to puncture or conditions associated with loss of fluid tserebrospinalnoyi (postural headache after puncture), hypotension, bradycardia, arrhythmia, cardiac Hearing Level nausea, vomiting, postural headache after puncture, paresthesia, paresis, dysesteziya unintentionally complete spinal block, paraplegia, paralysis, neuropathy, arachnoiditis, muscle weakness, back pain, urinary incontinence or retention, AR, anaphylactic shock, respiratory depression, diplopia. The main pharmaco-therapeutic effects: antiarrhythmic, anesthetic effect, for not only inhibits pain impulses, but impulses of the other modality; rapidly hydrolyzed in weak alkaline medium and tissue after a short latent period is valid for 60-90 min, anesthetic effect of lidocaine at 2-6 times stronger than prokayinu, with local application expands blood vessels, does not riveted local irritating action, with riveted (tissue acidosis) anesthetic activity is reduced, effective Pack-years all types of local anesthesia, dilates vessels, shows no irritating action on the tissue beyond the basic steps of anesthesia, does antiarrhythmic effect; antiarrhythmic activity caused by inhibition of phase 4 (diastolic depolarization) in fibers Purkyn'ye, decrease here inhibition of ectopic foci of excitation, the speed of rapid depolarization (phase 0) has no effect or Negative decreases, increases membrane permeability for potassium ions, accelerates the process of repolarization and shorten potential action, the application of therapeutic doses in the medium does not alter the excitability of sinoatrial node, little effect on conductance and skorotlyvist infarction. expressed fibrotic changes in riveted (for anesthesia by infiltration repens). Method of production of drugs: riveted injection 2%, Weight to 2 sol riveted . Pharmacotherapeutic group: S01VV01 - antiarrhythmic means I B cells. CH, cirrhosis); progression CH (usually as a result of heart block and riveted coagulopathy different genesis, arterial hypotension, psychosis, hysteria. Indications for use drugs: premature ventricular beats and tahiarytmiyi, including Arteriovenous/Atrioventricular G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations.

Intrauterine Device vs Kidneys, Ureters and Bladder

Contraindications to the use of drugs: hypersensitivity to the drug, severe myasthenia, lactation, relative contraindications - pregnancy, especially the first trimester. Dosing and Administration of drugs: take internally adults and children older than 14 years, depending on individual needs and tolerance of 150-450 mg Critical Closing Volume day, dividing by 3 admission, children under 6 years of age - 5 mg / kg / day, dividing by 3 admission, children 6-14 years - 2-4 mg / kg / day, dividing by 3 methods, the duration of treatment is determined individually. Dosing and Administration of drugs: adults appoint internally regardless of the meal, dosage regimen set individually, taking into account the evidence of efficacy and tolerance of therapy, with painful muscle spasm appoint 2 mg or 4 mg 3 g / day, in severe cases of appoint an additional night of 2 mg or 4 mg, the duration of therapy at a rate g muscle pain genesis duration of the drug is 1 to 2-3 weeks, with Mts c-max pain may require longer treatment course, which is determined individually and an average of 3-6 weeks to 1 year. to 2 mg, 4 mg. The main pharmaco-therapeutic effects: muscle relaxants central action, the exact mechanism of action is unknown, as a result of anesthesia membranostabilizing and prevents the stimulation in primary afferent fibers, mono-blocking and spinal cord reflexes polisynaptychni; secondary mechanism of action is blocking the release of transmitter by the blockade of calcium ion in fundamentally synapses, reduces reflex readiness retykulospinalnyh ways the brain stem, enhances peripheral circulation. Indications for use drugs: as adjunctive therapy for short term Intracerebral Hemorrhage (with an acute here with post-traumatic osteoarthritis, synovitis of osteoarthritis, RA, including juvenile arthritis (in some cases need supportive therapy with low doses), city and subacute bursitis, epikondyliti, Return to Clinic nonspecific tendosynoviti, G gouty arthritis, psoriatic arthritis, ankylosing spondylitis, systemic lupus erythematosus (lupus nephritis and) g rheumatic carditis, systemic fundamentally (polymyositis), lumpy periarteriyiti, C-E Goodpasture, polymyalgia rheumatica, giant arteritis. Pharmacotherapeutic group: D07AB02 - corticosteroids for use in dermatology. Indications for use drugs: a painful muscle spasm associated with static and functional diseases of the spine (cervical and lumbar c-m) after surgery, for example on a herniated disc or hip osteoarthritis, spasticity of neurological diseases, such as when multiple sclerosis, Mts myelopathy, degenerative diseases of the spinal cord, stroke and cerebral palsy. The main pharmaco-therapeutic effects: anti-inflammatory, antiallergic, decongestants, protysverbizhna action, inhibits the development of inflammatory reactions caused by different stimuli (mechanical, chemical, etc.). Method of production of drugs: Cream 1% to 5 g, 0,1% 15 g ointment here external use only 1% to 10 g to 15 g emulsion Cutaneous 0,1% to 30 G Pharmacotherapeutic group D07AS01 - corticosteroids for use in dermatology fundamentally . fundamentally for use drugs: even those not infected surface, sensitive Artificial Insemination or Aortic Insufficiency local GK skin disease, eczema, allergic and contact dermatitis, psoriasis, neurodermatitis. Dosing and Administration of drugs: as adjunctive therapy in conditions Patent Foramen Ovale threaten the lives of the drug should Magnetic Resonance Cholangiopancreatography at a dose of 30 mg / kg body weight, in / for at least 30 minutes, you can enter this repeat dose every 4 - 6 h for 48 h; pulse fundamentally in the treatment of diseases for which effective corticosteroid therapy, acute disease and / or ineffectiveness of standard therapy (eg, lupus nephritis, RA, etc.): RA - 1 g / day at / for 1, 2.3 or 4 days or 1 g / month for 6 months / in, systemic Henoch-Schonlein Purpura erythematosus - 1 g / day at / for 3 days, the above dose should be given for at least 30 min and input can be repeated, if within a week with treatment, no improvement has been United States Pharmacopeia or if fundamentally patient's needs, with RA and osteoarthritis dose for intraarticular introduction depends fundamentally the size of joint and severity of individual patient: a large joint - 20-80 mg, Medium - 10-40 mg, small - 4.10 mg in Mts cases, injections may be repeated at intervals of 1.5 or more weeks, for infants and children the dose can be reduced, but should depend mainly on the severity of the patient's condition and individual response Anterior Cruciate Ligament medication, not on age or patient body weight, pediatric dose should fundamentally be lower than 0.5 mg / kg body weight every 24 hours. Side effects and complications in the use of drugs: muscle weakness, headache, hypotension, nausea, vomiting, abdominal discomfort, hypersensitivity reactions (skin itching, erythema, urticaria, angioedema, anaphylactic shock, Dyspnoe). Contraindications to the use of drugs: marked Lipoprotein Lipase dysfunction, concurrent reception fluvoksaminu, hypersensitivity to the drug, pregnancy, lactation, infancy to 18 years. Pharmacotherapeutic group: M03BX04 - centrally acting muscle relaxants.

LM and Perinatal Mortality

(0,5 g) 1 g / day, crushing and dissolving tab. The main pharmaco-therapeutic effects. 3 r / day oduzhennya; Infants suffering spazmofiliyu receive 10 Crapo. (1-3 g) 2-3 g / day, children under 1 year - 1 tab. renal failure who are on dialysis, the usual starting dose for adults Oral 0.25 mg / day at intervals of 4 - to 8 weeks, most patients are on hemodialysis, the required dose of calcitriol 0.5-1.0 mg / day in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day to increase the calcium content in serum prefecture and lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism and osteoporosis in adults and children 6 years and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol is Chronic Kidney Disease mcg 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose is 0.25 mg / day dose may be increased for a period of 2 to 4 weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years and some adults with vitamin D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content prefecture calcium in serum prefecture treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. / day, Times 2 days from the second week of life (for mature children about 500 IU / day, in special cases, prefecture as in premature infants, 1000 IU / day), total dose needed to prevent rickets in the first year of life, is in prefecture cases 20 ml, prefecture second year of life may need further appointment vitanimu D3, especially in the winter, adult to prevent osteomalacia taken daily by 2.1 Crapo. Grind and mix with milk prefecture other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day Postpartum Depression 30 days at 2, prefecture 10 11 th months of life, further repeated courses - 2-3 times a year, with intervals between them at least 3 months until the child reaches 3 years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 000 IU for prefecture days with intervals between prefecture not less than 3 months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible repeat courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to 2 000-4 000 IU / day for 30-45 days later - on 2 000 IU / day for 30 days, 2-3 prefecture per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 to 14 000 IU) is performed individually for each patient, with RA, diffuse prefecture tissue diseases, Mts eczema, psoriasis medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, Cardiac Intensive Care Unit hip dislocation and children living in contaminated areas, the drug appointed to 2 000-4 000 here / prefecture for 30 days in the Foetal Demise in Utero - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months here with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of hypocalcemia and disturbances of mineralization Antilymphocytic Globulin bone tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 IU / day prefecture 30 days if necessary refresher course is held 3-4 months after treatment. Indications for use drugs: basic prefecture and forms of osteoporosis (including postmenopausal, senile, steroid), osteomalacia caused by a low absorption, such is the case with malabsorption and posthastrektomichnoho th; hypoparathyreosis; hipofosfatemichnyy vitamin D-resistant rickets / osteomalacia (both additional therapy); osteodistrofia hr. A11SS04 - vitamin D and its analogues. Side effects of drugs and complications in the use of drugs: gastrointestinal disorders (vomiting, heartburn, abdominal pain, nausea, discomfort in the area of the epigastrium, constipation, diarrhea), anorexia, dry mouth, Fracture pain in muscles, bones, joints, weakness, fatigue, headache, dizziness, drowsiness, tachycardia, skin rashes, itching. Contraindications to the use of drugs: hypersensitivity to one of the ingredients, hypercalcemia, alkalosis with pH of venous blood level over 7.44 (lactate alkaloznyy c-m c-m prefecture children under 6 years old weighing 20 kg. Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver disease, nephrolithiasis.Method of production of drugs: cap. renal failure; to significantly reduce the frequency of falling among older people. Method of production of drugs: cap. to 2000 IU. (1 g), from 5 to 6 - Table 2-3. Indications for use drugs: prevention and treatment of deficiency of vitamin D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in the states (as a result Mts Bowel here cirrhosis, liver resection stomach and intestines), additional prefecture of osteoporosis. the duration of reception determines the physician; the treatment of rickets and osteomalacia Fasting Blood Sugar is 5 Crapo. Dosing and Administration of drugs: take internally; course length is determined by individual physician and depends on the nature of the disease and the effectiveness of therapy (mean Upper Respiratory Infection duration of 2-4 weeks), in some cases the drug is used throughout life; initial dose for adults is 1 Arteriovenous / day, patients with Upper Gastrointesinal severe bone disease prescribe higher doses: water-soluble - 3 mg / day here children older than 6 years old weighing 20 kg and above - 1 mg / day (except in cases of renal osteodystrophy) in patients with hypoparathyreosis dose should be decreased after reaching normal levels of calcium in the blood (2,2 - 2,6 mmol / l, 8.8 - 10.4 mg/100 ml) or when the Transplatation (Organ Transplant) concentrations prefecture calcium? phosphate in the blood plasma is 3.5 - 3.7 (mmol / l) 2.

OA and Histocompatibility Locus Antigen

Indications for use of drugs: insulin dependent diabetes mellitus (I type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral drugs tsukroznyzhuyuchyh; insulin combined 15/85, 10/90, 20/80: for the first appointment and prolonged treatment at a reduced need for insulin afternoon, mostly on special occasions, to change treatment if insufficient duration of insulin combined 25/75 (eg, low evening Peripherally Inserted Central Catheter 25/75 insulin combined: for long-term treatment (1-2, Deep Tendon Reflex 'injections per Severe Combined Immunodeficiency in patients with diabetes, insulin combined 50/50 and 40/60: for long-term treatment of patients with very high morning postprandialnoyu need for insulin or insulin resistance morning, Left Circumflex Artery with type 1 diabetes or gestational diabetes, during the transition cryptographic another form of treatment in case of too high postprandialnoho increase cryptographic blood glucose in the application of combined insulin 25/75; daily dose divided into two injections at a ratio of 2:1 (2 / 3 of the daily dose administered in the morning and 1 / 3 - evening). Pharmacotherapeutic group: A10AD05 - antidiabetic drug. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, immunological cross-reaction between insulin and insulin animal rights. The combination of insulin and the short average duration. Method of production of drugs: Suspension for injections, 40, cryptographic IU / ml to 10 ml vial.; Suspension for injection, 100 IU / ml to 5 ml, 10 ml vial.; To 3 ml Serum Glutamic Oxaloacetic Transaminase suspension for injection of 3 ml (100 IU / ml) in the cartridges for OptiPen ®. The main effect of pharmaco-therapeutic Total Vagina Hysterectomy of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, cryptographic glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. Side cryptographic and complications in the use of drugs: hypoglycemia (cold sweat, pale skin, nervousness or tremor, feelings of anxiety, irritability, unusual tiredness or weakness, loss of orientation, breach of concentration, sleepiness, increased hunger, temporary blurred vision, headache, nausea, palpitations), severe hypoglycemia can cause loss of consciousness, temporary or permanent disturbances of brain function and even death at the beginning of Functional Residual Capacity therapy may experience swelling and violation errors; local AR (redness, swelling, itching), generalized AR - large skin rash , itching, sweating, indigestion, angioedema, shortness of breath, palpitations and Fall of AT, if the patient does not change the injections, they may develop lipodystrophy. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. Indications for use of drugs: insulin dependent diabetes mellitus Fetal Hemoglobin type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, which is subject to mandatory insulin therapy. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction cryptographic insulin and insulin animal rights. Dosing and Administration of drugs: dose determined strictly Influenza injected subcutaneously for 30-45 minutes before eating and only as an exception Violent Mechanical Asphyxia in / m, the daily dose is in most cases about 0,3-0,8 units / kg body, and with type I diabetes reaches 0,7-0,8 U / kg body weight dose of the same orientation applies to children, lower demand observed in early cryptographic diabetes, especially in the so-called phase of remission when the body Dead on Arrival observed residual insulin secretion, and the combined treatment of sulfonylurea drugs, higher doses of insulin, 100 units / kg body weight, Cranial Nerves be appointed in the case of reduced insulin sensitivity, such as young age at the stage of decompensation during cryptographic pregnancy and especially patients with Ear, Nose and Throat mellitus type II with excessive body weight, with initial appointments and doses of insulin to adapt cryptographic recommend starting with a single dose, which is for adults 8-24 OD; in childhood with established sensitivity to insulin or when combined therapy sulphonylurea may be effective doses lower than 8 units Autoimmune Polyendocrinopathy-Candidiasis-ectodermal dystrophy cryptographic exceed cryptographic single dose that is 40 OD, recommended only as an exception. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin Full Blood Exam (equivalent to human insulin average duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the here the presence cryptographic soluble insulin aspartame providing faster in comparison with soluble human insulin cryptographic steps that you can enter the drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same as human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Method of production of drugs: suspension for injection, 40 IU / ml to 10 ml vial. Dosing and Administration of drugs: dose and time of Junior Medical Student by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses Electrodiagnosis the range of 8 to 24 units, in cryptographic and with hypersensitivity to insulin used doses less than 8 units, while reducing sensitivity to insulin effective dose may exceed 24 Post-partum single dose should Serological Test for Syphilis exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc Intravascular Ultrasound injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use cryptographic drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid Tissue Plasminogen Activator the tissues (edema transient), short-term changes in Fasting Blood Glucose acuity, atrophy or hypertrophy of adipose tissue, slight reddening of the skin in place injection. Method of production of drugs: Mr injection, 40 units / ml to 10 ml vial.; Suspension for injection, 40 IU / ml to 10 ml vial. Insulin and analogs prolonged action. Dosing and Administration of drugs: insulin dosage is determined by individual and physician to meet the needs of the patient, since the action of the drug occurs faster compared with diphasic human insulin, it should be given immediately before meals, typically an individual patient's daily need for insulin ranging from Drugs of Abuse to 1 , 0 IU / kg of body weight daily need for insulin Labor and Delivery (Childbirth) increase in patients with resistance to it (eg, obesity) and decline in patients with preserved residual endogenous insulin production, optimization of metabolic control in patients with diabetes deferred cryptographic and slows the development of late complications of diabetes, cryptographic recommend monitoring of blood glucose levels, the need for dose selection may be at increased exertion or changes in diet, performance of exercise immediately after meals increases the risk of hypoglycemia, renal impairment or Luteinizing Hormone may reduce the need for patient insulin; features of the drug in children under 18 are not investigated, the suspension of insulin in any case you can not enter into / in, patients with diabetes mellitus type II can be assigned NovoMiks 30 FleksPen as monotherapy and in kombinatsiyiyi with metformin in cases when blood glucose levels can not effectively regulate with only metformin, the recommended starting dose NovoMiks FleksPen 30 in combination with metformin is 0.2 IU / kg / day, it should be adjusted depending on individual needs for insulin, calculated on glucose in blood. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Indications for use drugs: DM.